About Collplant Biotechnologies
CollPlant Biotechnologies is a regenerative medicine company focused on 3D bioprinting of tissues and organs, and also develops and markets tissue repair products for orthobiology.
The Innovative Technologies and Products of CollPlant Biotechnologies are the Ideal Building Block for Regenerative Medicine: CollPlant Biotechnologies' products are based on our revolutionary plant-based technology that enables the production of recombinant human type I collagen (rhCollagen), which is identical to the collagen produced by the human body. Based on the unique properties of our BioInks and our expertise in biomaterials, CollPlant Biotechnologies is developing a pipeline of products for 3D bioprinting of tissues and organs as well as for medical aesthetics. CollPlant Biotechnologies' rhCollagen is identical to the type I collagen produced by the human body, making it the ideal building block for regenerative medicine. CollPlant Biotechnologies is advancing collaborations with leading companies in the field of regenerative medicine by licensing our rhCollagen technology platform for the development of ground-breaking products.
CollPlant Biotechnologies’ Founding And Headquarters: CollPlant Biotechnologies was founded in 1981 by Oded Shoseyov. CollPlant Biotechnologies is currently headquartered in Rehovot, HaMerkaz, Israel.
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Collplant Biotechnologies
11 Feb 2024
CollPlant Biotechnologies (Biotechnology company)
CollPlant Biotechnologies Ltd. operates as a regenerative medicine company. The Company focuses on the 3D bioprinting of tissues and organs, as well as on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CURRENT PRICE. CLGN:US5.68USD.bloomberg.com/profile/company/CLGN:US#:~:text=CollPlant%20Biotechnologies%20Ltd.,CLGN%3AUS5.68USD
Stock price : CLGN (NASDAQ) US$5.51 -0.09 (-1.52%)9 Feb, 16:00 GMT-5 - Disclaimer
Headquarters : Israel
Founded : 2004